Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on TEVA PHARMACEUTICAL INDUST
07/24 TEVA PHARMACEUTICAL INDUSTRIES : employees in Israel take industrial action
07/24 TEVA PHARMACEUTICAL INDUSTRIES : Announces the Launch of Generic Vagifem® in the..
07/24 TEVA PHARMACEUTICAL INDUSTRIES LTD ( : TEVA) Turns To Layoffs In Israel To Impro..
07/23 TEVA PHARMACEUTICAL INDUSTRIES : to lay off 300-350 in Israel
07/23 TEVA PHARMACEUTICAL INDUSTRIES : Pharmaceutical giant Teva to lay off employees ..
07/20 TEVA PHARMACEUTICAL INDUSTRIES : and the Huntington Study Group Announce Publica..
07/20 TEVA PHARMACEUTICAL INDUSTRIES : to Report Second Quarter 2017 Financial Results..
07/20 TEVA PHARMACEUTICAL INDUSTRIES : NICE Recommends CINQAERO® (reslizumab) for the ..
07/18 TEVA PHARMACEUTICAL INDUSTRIES : European Commission Sends Statement of Objectio..
07/17 TEVA PHARMACEUTICAL INDUSTRIES : EU regulators charge Teva over pay-for-delay dr..
07/16 ASTRAZENECA : Soriot not moving to Teva - Bloomberg
07/14DJASTRAZENECA : CEO? We Still Don't Know If He's Staying or Going
07/14 ASTRAZENECA : offers no comment after report saying CEO staying
07/13 ASTRAZENECA : Pascal Soriot candidate for Teva CEO - report
07/13 AstraZeneca holds FTSE back, Carillion loses last 'buy' rating
07/13 TEVA PHARMACEUTICAL INDUSTRIES : Enhances Board of Directors as All Proposals Ap..
07/13DJMYSTERY AT ASTRAZENECA : Is CEO Soriot Staying or Going?
07/13 PASCAL SORIOT : AstraZeneca's CEO Soriot to join Israeli drugs company Teva - re..
07/11 TEVA PHARMACEUTICAL INDUSTRIES : to Report Second Quarter 2017 Financial Results..
07/11 TEVA PHARMACEUTICAL INDUSTRIES : and the Huntington Study Group Announce Publica..
07/11 TEVA PHARMACEUTICAL INDUSTRIES : G-BA confirms Teva`s Cinqaero gives minor addit..
07/10DJU.K. COURT : Generics Infringe Eli Lilly's Patents on Alimta -- WSJ
07/07DJU.K. Court Says Generics Infringe on Lilly's Alimta Patents -- Update
07/07DJU.K. Court Says Generics Infringe on Lilly's Alimta Patents
07/07 UK Supreme Court rules in favour of Lilly's Alimta patents
07/07 VIVUS, INC. (NASDAQ : VVUS) Settles With Teva Pharmaceutical Industries Ltd (ADR..
07/07DJTEVA PHARMACEUTICAL INDUSTRIES : Generics Group Sues Maryland -- WSJ
07/06DJTEVA PHARMACEUTICAL INDUSTRIES : Maryland Sued by Generic-Drug Trade Group Over ..
07/06DJTEVA PHARMACEUTICAL INDUSTRIES : Maryland Sued by Generic-Drug Trade Group Over ..
07/06 TEVA PHARMACEUTICAL INDUSTRIES : and Xenon Announce Phase II Study of Topical TV..
07/05 TEVA PHARMACEUTICAL INDUSTRIES : India central to medicine maker's agenda
06/30DJOklahoma Sues Opioid Painkiller Makers -- 2nd Update
06/30DJOklahoma Sues Opioid Painkiller Makers -- Update
06/30DJOklahoma Sues Opioid Painkiller Makers
06/30 TEVA PHARMACEUTICAL INDUSTRIES (NYSE : TEVA) Executive Yitzhak Peterburg Claims ..
06/29 TEVA PHARMACEUTICAL INDUSTRIES : Celltrion and Teva Announce U.S. FDA Acceptance..
06/29 TEVA PHARMACEUTICAL INDUSTRIES : Announces Publication of AIM-TD Study Results i..
06/28 TEVA PHARMACEUTICAL INDUSTRIES : and Xenon Announce Phase II Study of Topical TV..
06/28 TEVA PHARMACEUTICAL INDUSTRIES LTD ( : TEVA), Xenon Pharmaceuticals Inc (NASDAQ:..
06/27 NETWORKNEWSBREAKS – XENON PHAR : XENE) and Teva Pharmaceutical’s (NY..
06/27 XENON PHARMACEUTICALS INC. (NASDAQ : XENE) Files An 8-K Other Events
06/27 TEVA PHARMACEUTICAL INDUSTRIES : and Xenon Announce Phase II Study of Topical TV..
06/22 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Pataday® ..
06/22 TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of Generic Zetia® in the Unite..
06/22 TEVA PHARMACEUTICAL INDUSTRIES : loses $235m patent trial to GSK
06/19 TEVA PHARMACEUTICAL INDUSTRIES : AbCellera expands research collaboration with T..
06/16 TEVA PHARMACEUTICAL INDUSTRIES : embroiled in Copaxone dosage levels dispute
06/15 TEVA PHARMACEUTICAL INDUSTRIES : Fremanezumab Meets all Primary & Secondary Endp..
06/15 CTI BIOPHARMA : Hikes on Teva Milestone Payment
06/14 TEVA PHARMACEUTICAL INDUSTRIES : launches generic cholesterol treatment
06/14 TEVA PHARMACEUTICAL INDUSTRIES : launches generic allergic eye treatment Pataday..
06/13 TEVA PHARMACEUTICAL INDUSTRIES : launches generic cholesterol treatment
06/13DJTEVA PHARMACEUTICAL INDUSTRIES : Nassau Sues Drugmakers Over Opioids -- WSJ
06/12DJTEVA PHARMACEUTICAL INDUSTRIES : Nassau County Sues Drugmakers Over Opioid Epide..
06/12 TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of Generic Zetia® in the Unite..
06/12DJTEVA PHARMACEUTICAL INDUSTRIES : Nassau County Sues Drug Makers Over Opioid Epid..
06/11 TEVA PHARMACEUTICAL INDUSTRIES : launches generic conjunctivitis treatment
06/09 TEVA PHARMACEUTICAL INDUSTRIES : Announces Positive Results for Phase III Study ..
06/09 TEVA PHARMACEUTICAL INDUSTRIES : to Present Data from 18 Abstracts in Tardive Dy..
06/09 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Pataday® ..
06/09DJTEVA PHARMACEUTICAL INDUSTRIES : Aims To Reshape Its Board -- WSJ
06/08DJTEVA PHARMACEUTICAL INDUSTRIES : to Nominate Four New Directors
06/08 TEVA PHARMACEUTICAL INDUSTRIES : Fremanezumab meets all Primary and Secondary En..
06/07 Mylan defends chairman to ISS ahead of June 22 investor vote
06/07 TEVA PHARMACEUTICAL INDUSTRIES : Fremanezumab Meets all Primary & Secondary Endp..
06/06 TEVA PHARMACEUTICAL INDUSTRIES : to Present at the Jefferies 2017 Global Healthc..
06/05 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : ex-dividend day for interim dividend
06/02 TEVA PHARMACEUTICAL INDUSTRIES : to Present Data from 18 Abstracts in Tardive Dy..
06/02 TEVA PHARMACEUTICAL INDUSTRIES : reports positive Phase III migraine trial
06/02 TEVA PHARMACEUTICAL INDUSTRIES : announces success chronic migraine headache dru..
06/01 TEVA PHARMACEUTICAL INDUSTRIES LTD ( : TEVA) Succeeds in Phase III HALO Study Of..
06/01 TEVA PHARMACEUTICAL INDUSTRIES : to Present Data from 18 Abstracts in Tardive Dy..
06/01DJOpioid Makers Sued for Stoking Addiction -- WSJ
06/01DJOhio Sues Five Drug Firms, Saying They Fueled Opioid Crisis -- 2nd Update
05/31DJOhio Sues Five Drug Firms, Saying They Fueled Opioid Crisis -- 2nd Update
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 23 489 M
EBIT 2017 7 190 M
Net income 2017 4 011 M
Debt 2017 25 854 M
Yield 2017 3,68%
P/E ratio 2017 8,30
P/E ratio 2018 8,03
EV / Sales 2017 2,51x
EV / Sales 2018 2,34x
Capitalization 33 063 M
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 37,5 $
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Yitzhak Peterburg President & Chief Executive Officer
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael R. Hayden President-Global Research & Development
Roger Abravanel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-16.27%33 063
JOHNSON & JOHNSON15.45%358 307
ROCHE HOLDING LTD.4.90%221 333
NOVARTIS8.37%220 169
PFIZER2.59%198 425
MERCK AND COMPANY6.29%171 139